Log in to post a reply
Jan 2, 2016 06:35PM
Jan 2, 2016 06:45PM
For what it is worth, here is a link to PREDICT. You may not have all the information needed at this point.
SpecialK explained elswhere that PREDICT: ". . . is a potentially a better tool for those of us who are Her2+, as cancermath does not factor in targeted therapy for Her2+ patients, so the result it produces may not be as accurate. This is a site form the UK and so remember to put your tumor size in with mm, not cm - just multiply your cm by 10 to get the correct number."
Also for what it is worth, Cancermath is found here:
In another thread, you mentioned a "lobular" diagnosis, which is less common than ductal carcinoma. I do not know anthing about the predictive value of these programs for lobular disease.
Be sure to read all the associated caveats and limitations for both, and remember that these estimates are based on populations. At the individual level, recurrence happens or it does not.
Here are links to threads where members asked similar questions about pursuing treatment. The problem is that there is no way to know the outcome in the individual case. If your mother is one of the ones who is successfully treated and evades recurrent disease, she may live out her full life-span and it would be well worth it. Navigate to the very beginning of each thread.
Stage IA IDC, 9/2013 BMX. Right: IDC (1.5 mm, grade 2) with DCIS (5+ cm), 0/4 nodes, pN0. Left: DCIS (5+ cm), 0/1 node, pN0(i+).